Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence
Phase of Trial: Phase II
Latest Information Update: 19 Feb 2018
Price : $35 *
At a glance
- Drugs Gallium 68 PSMA (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Diagnostic use
- 13 Feb 2018 Status changed from not yet recruiting to recruiting.
- 08 Feb 2018 Planned initiation date changed from 1 Jan 2018 to 1 Feb 2018.
- 15 Jan 2018 New trial record